Team:Westminster/Team

From 2012.igem.org

(Difference between revisions)
Line 171: Line 171:
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
-
<h2>Lorem Ipsum</h2>
+
<div id="three-columns">
-
<p>The Westminster iGEM 2012 team aims to combat cancer recurrence by using one key feature of CSCs – increased Aldehyde Dehydrogenase (ALDH) activity. We have used the promoters of 4 different ALDH isoforms present in aggressive forms of cancer to design 3 constucts that will allow us to identify, isolate and eliminate CSC, offering a novel tool for the study of this cells and a potential new anti-cancer therapy for the future.</p>
+
<div class="column text-box">
 +
<h3>Lorem Ipsum</h3>
 +
<p>Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam sit amet elit vitae arcu interdum ullamcorper. Nullam ultrices, nisi quis scelerisque convallis, augue neque tempor enim, et mattis justo nibh eu elit.</p>
 +
</div><!-- .column -->
 +
<div class="column text-box">
 +
<h3>Lorem Ipsum</h3>
 +
<p>Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam sit amet elit vitae arcu interdum ullamcorper. Nullam ultrices, nisi quis scelerisque convallis, augue neque tempor enim, et mattis justo nibh eu elit.</p>
 +
</div><!-- .column -->
 +
<div class="column text-box">
 +
<h3>Lorem Ipsum</h3>
 +
<p>Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam sit amet elit vitae arcu interdum ullamcorper. Nullam ultrices, nisi quis scelerisque convallis, augue neque tempor enim, et mattis justo nibh eu elit.</p>
 +
</div><!-- .column -->
 +
</div><!-- #three-columns -->
</div><!-- #home-main-text -->
</div><!-- #home-main-text -->

Revision as of 19:36, 25 September 2012

Welcome

Lorem Ipsum

Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.

Lorem Ipsum

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam sit amet elit vitae arcu interdum ullamcorper. Nullam ultrices, nisi quis scelerisque convallis, augue neque tempor enim, et mattis justo nibh eu elit.

Lorem Ipsum

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam sit amet elit vitae arcu interdum ullamcorper. Nullam ultrices, nisi quis scelerisque convallis, augue neque tempor enim, et mattis justo nibh eu elit.

Lorem Ipsum

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Etiam sit amet elit vitae arcu interdum ullamcorper. Nullam ultrices, nisi quis scelerisque convallis, augue neque tempor enim, et mattis justo nibh eu elit.

Retrieved from "http://2012.igem.org/Team:Westminster/Team"